Bladder cancer in women

International Urogynecology Journal

Volumn 10, Issue 6, 1999, Pages 399-404

  Baniel, J ^a  

^a RABIN MEDICAL CENTER   (Israel)

Author keywords

Bladder cancer; Transitional cell carcinoma; Vesical tumors

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; BCG VACCINE; CISPLATIN; DOXORUBICIN; ETOGLUCID; METHOTREXATE; MITOMYCIN C; THIOTEPA; VINBLASTINE;

ARTHRALGIA; BLADDER CANCER; BONE MARROW SUPPRESSION; CANCER GRADING; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CYSTOSCOPY; DIAGNOSTIC IMAGING; DRUG COST; DYSURIA; FEMALE; FLU LIKE SYNDROME; GRANULOMA; HEMATURIA; HEPATITIS; HUMAN; IMMUNOTHERAPY; MORBIDITY; ONSET AGE; ORCHITIS; PRIORITY JOURNAL; PROGNOSIS; RADIODIAGNOSIS; REVIEW; SEPSIS; TRANSURETHRAL RESECTION; TREATMENT FAILURE;

EID: 0033406287     PISSN: 09373462     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001920050068     Document Type: Review

References (59)

1. Johansson SL, Cohen SM. Epidemiology and etiology of bladder cancer. Semin Surg Oncol 1997;13:291-298
2. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1997. CA Cancer J Clin 1997;47:5-27
3. Kantor AF, Hartage P, Hoover RN, Fraumeni JF Jr. Epidemiological characteristics of squamous cell carcinoma and adenocarcinoma of the bladder. Cancer Res 1988;48:3853-3855
4. Parkin DM, Muir CS, Whelan SL, GAO Y-T, Ferlay J, Powell J (eds). Cancer Incidence in five continents, vol VI. International Agency for Research on Cancer scientific publications No 120. Lyon, 1992.
5. Wan J, Grossman B. Bladder carcinoma in patients age 40 years or younger. Cancer 1989;64:178-181
6. Silverman DT, Hartage P, Morrison AS, Devesa SS. Epidemiology of bladder canceer. Hematol Oncol Clin N Am 1992;6:1-30
7. Silverman DT, Levin LI, Hoover RN et al. Occupational risks of bladder cancer in the United States: I. White men. J Natl Cancer Inst 1989;81:1472-1480
8. Silverman DT, Levin LI, Hoover RN et al. Occupational risks of bladder cancer in the United States: II. Nonwhite men. J Natl Cancer Inst 1989;81:1480-1483
9. Silverman DT, Levin LI, Hoover RN et al. Occupational risks of bladder cancer among white women in the United States. Am J Epidemiol 1990;132:453-461
10. La Vecchia C, Negri E, D'Avanzo B et al. Occupation and risk of bladder cancer. Int J Epidemiol 1990;19:264-268
11. Silverman DT, Hoover RN, Mason TJ et al. Motor exhaustrelated occupations and bladder cancer. Cancer Res 1986;46:2113-2116
12. Claude JC, Frentzel-Beyme RR, Kunze E. Occupation and risk of cancer of the lower urinary tract among men. A case-control study. Int J Cancer 1988;41:371-379
13. Augustine A, Hebert JR, Kabat GC et al. Bladder cancer in relation to cigarette smoking. Cancer Res 1988;48:4405-4408
14. Burch JD, Rohan TE, Howe GR et al. Risk of bladder cancer by source and type of tobacco exposure: a case-control study. Int J Cancer 1989;44:622-628
15. Clavel J, Cordier S, Boccon-Gibod L, et al. Tobacco and bladder cancer in males: increased risk for inhalers and smokers of black tobacco. Int J Cancer 1989;44:605-610
16. D'Avanzo B, Negri E, La Vecchia C et al. Cigarette smoking and bladder cancer. Eur J Cancer 1990;26:714-718
17. Howe GR, Burch JD, Miller AB et al. Tobacco use, occupation, coffee, various nutrients, and bladder cancer. J Natl Cancer Inst 1980;64:701-713
18. International Agency for the Research on Cancer (IARC) monographs on the evaluation of carcinogenic risks to humans. Volume 61, Schistosomes, liver flukes and Helicobacter pylori. IARC. 1994, Lyon, France
19. Quilty PM, Kerr GK. Bladder cancer following low or high dose pelvic radiation. Clin Radiol 1987;38:583-585
20. Cummings KB, Barone JG, Ward WS. Diagnosis and staging of bladder cancer. Urol Clin N Am 1992;19:455-465
21. Bergvist A, Ljungquist A, Moberger G. Classification of bladder tumors based on the cellular pattern: preliminary report of a clinical pathological study of 300 cases with a minimum follow up of 8 years. Acta Chir Scand 1965;130:351-354
22. Lantz EJ, Hattery RR. Diagnostic imaging of urothelial cancer Urol Clin N Am 1984;11:567-583
23. Kantor AF, Hartage P. Hoover RN, Fraumeni JF Jr. Epidemiological characteristics of squamous cell carcinoma and adenocarcinoma of the bladder. Cancer Res 1988;48:3853-3855
24. American Joint Committee on Cancer. Manual for staging cancer 1983. Philadelphia: JB Lippincott, 1983:171
25. Heney MN, Ahmed S, Flanagan MJ et al. Superficial bladder cancer: Progression and recurrence. J Urol 1983;130:1083-1086
26. Lamm DL, Thor DE, Harris SC et al. Bacillus Calmette-Guérin immunotherapy of superficial bladder cancer. J Urol 1980;124:38-40
27. Martinez-Piñeiro JA, Jimenez Leon J, Marinez-Piñeiro L et al. Bacillus Calmette-Guérin versus doxorubicin versus thiotepa: a randomized prospective study in 202 patients with superficial bladder cancer. J Urol 1990;143:502-506
28. DeBruyne FM, van der Meijden AP, Geboers AD et al. BCG (RIVM) versus mitomycin intravesical therapy in superficial bladder cancer: first results of a randomized prospective trial. Urology 1988;31(Suppl 3):20-25
29. Herr HW, Laudone VP, Badalament RA et al. Bacillus Calmette-Guérin therapy alters the progression of superficial bladder cancer. J Clin Oncol 1988;6:1450-1455
30. Coplen DE, Marcus MD, Myers JA et al. Long-term follow-up of patients treated with 1 or 2, 6-week courses of intravesical bacillus Calmette-Guérin: analysis of possible predictors of response free of tumor. J Urol 1990;144:652-657
31. Hudson MA, Ratliff TL, Gillen DP, Haaff EO, Dresner SM, Catalona WJ. Single course versus maintenance bacillus Calmette-Guérin therapy for superficial bladder tumors: a prospective, randomized trial. J Urol 1987;138:295-298
32. Badalament RA, Herr HW, Wong GY et al. A prospective randomized trial of maintenance versus non-maintenance intravesical bacillus Calmette-Guérin therapy for superficial bladder cancer. J Clin Oncol 1987;5:441-449
33. Lamm DL, Crawford ED, Blumenstein B, et al. Maintenance bacillus Calmette-Guérin immunotherapy of superficial bladder cancer: a randomized prospective Southwest Oncology Group study. J Urol 1992; Part 2, 147:274A, abstract 242
34. Jones HC, Swinney J. Thiotepa in the treatment of tumors of the bladder. Lancet 1961;2:615-616
35. Prout GR, Koontz WW Jr, Coombs J et al. Long term fate of 90 patients with superficial bladder cancer randomly assigned to receive or not to receive thiotepa. J Urol 1983;130:677-680
36. Lamm DL, Riggs DR, Traynelis CL, Nseyo UO. Apparent failure of current intra-vesical chemotherapy prophylaxis to influence the long-term course of superficial transitional cell carcinoma of the bladder. J Urol 1995;153:1444-1450
37. Morales A, Eidinger D, Bruce AW. Intracavitary bacillus Calmette-Guérin in the treatment of superficial bladder tumors. J Urol 1976;116:180-183
38. Lamm DL, Torti FM. Bladder cancer, 1996. CA Cancer J Clin 1996;46:93-112
39. Lamm DL, van der Meijden APM, Morales A et al. Incidence and treatment of complications of bacillus Calmette-Guérin intravesical therapy in superficial bladder cancer. J Urol 1992;147:596-600
40. Williams RD. Intravesical interferon alpha in the treatment of superficial bladder cancer. Semin Oncol 1988;15:10-13.
41. Barnes RW, Bergman RT, Hadley HT et al. Control of bladder tumors by endoscopic surgery. J Urol 1967;97:864-868
42. Lerner SP, Skinner E, Skinner DG. Radical cystectomy in regionally advanced bladder cancer. Urol Clin N Am 1992;19:713-723
43. Bricker EM. Bladder substitution after pelvic evisceration. Surg Clin N Am 1950;30:1511-1514
44. Olsson CA. Continent urinary diversion. J Urol 1984;132:1157-1158
45. Kock NG, Nilson AE, Nilsson LO et al. Urinary diversion via ileal reservoir: Clinical results in 12 patients. J Urol 1982;128:469-475
46. Rowland RG, Mitchell ME, Bihrle R et al. Indiana continent reservoir. J Urol 1987;137:1136-1139
47. Duckett JW, Snyder HM III. Use of the Mitrofanoff principle in urinary reconstruction. Urol Clin N Am 1986;13:271-274
48. Hautman RE, Egghart G, Frohnberg D et al. The ileal neobladder. J Urol 1988;139:39-43
49. Lange P, Reddy PK, Fraley EE. Total bladder replacement using detubularized sigmoid colon: technique and results. J Urol 1991;145:51-55
50. Marshall FF. Creation of a ileocolic bladder after cystectomy. J Urol 1988;139:1264-1268
51. Studer U, Ackermann D, Casanova GA et al. Three years' experience with an ileal low pressure bladder substitute. Br J Urol 1989;63:43-52
52. Stein JP, Grossfeld GD, Freeman JA et al. Orthotopic lower urinary tract reconstruction in women using the Kock ileal neobladder updated experience in 34 patients. J Urol 1997;158:400-405
53. Stenzl A, Colleseli K, Bartsch G. Update of urethra sparing approaches in cystectomy in women. World J Urol 1997;15:134-138
54. Stenzl A, Draxl H, Posch B, Colleseli K, Falk M, Batsch G. The risk of urethral tumors in female bladder cancer: can the urethra be used for orthotopic reconstruction of the lower urinary tract? J Urol 1995;153:950-955
55. Logothetis CJ, Johnson DE, Chang C et al. Adjuvant cyclophosphamide, doxorubicin, and cisplatin chemotherapy for bladder cancer: an update. J Clin Oncol 1988;6:1590-1596
56. Scher H, Herr H, Sternberg C et al. Neoadjuvant chemotherapy for invasive bladder cancer: experience the MVAC regimen. Br J Urol 1989;64:250-256
57. Skinner DG, Daniels JR, Russel DA et al. The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer. J Urol 1991;145:459-464
58. Sternberg CN, Yagoda A, Scher HI et al. Methotrexate, vinblastine, doxorubicin and cisplatin for advanced transitional cell cancer of the urothelium. Cancer 1989;64:2448-2459
59. Stein JP, Grossfeld GD, Ginsberg DA et al. Prognostic markers in bladder cancer a contemporary review of the literature. J Urol 1998;160:645-659